Literature DB >> 15850656

Cytokine and chemokine inter-regulation in the inflamed or injured CNS.

Trevor Owens1, Alicia A Babcock, Jason M Millward, Henrik Toft-Hansen.   

Abstract

The distinction between immune-regulatory and effector cytokines and chemokines, and neural growth and survival factors (neurotrophins) becomes increasingly blurred. We discuss here the role of immune cytokines and chemokines as mediators of innate glial responses in the central nervous system. Glial responses to axonal degeneration in the hippocampus dentate gyrus are initiated independently of immune involvement, following transection of afferent entorhinal (perforant path) axons. The glial responses that we measure involve early microglial and somewhat later astrocyte activations. Among the earliest responses are the expression of a wide profile of chemokines, and of the cytokine tumor necrosis factor-alpha (TNFalpha). The cytokine interferon-gamma (IFNgamma) is not normally produced in the CNS, but TNFalpha levels are enhanced if it is present. Viral vector-derived IFNgamma directly induces the expression of chemokines in the CNS, in the absence of any other inflammatory event, but the profiles differ from those induced by axotomy. Chemokines that bind the CCR2 receptor are implicated in traffic of macrophages and T cells to the denervated hippocampus. Innate responses in the immune system are directed by Toll-like receptors (TLR). Our recent studies focus on specific TLR signals as upstream on-switches for glial cytokine and chemokine responses. The biological activity of chemokines is regulated by matrix metalloproteinase enzymes (MMPs) and specific members of this family are expressed in response to axonal lesioning. These findings strengthen the case for the sharing of signals between the immune and nervous system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850656     DOI: 10.1016/j.brainresrev.2004.12.007

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  38 in total

1.  Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Annemarie Ledeboer; Julie Wieseler-Frank; Erin D Milligan; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

Review 2.  [The relevance of the inflammatory response in the injured brain].

Authors:  O I Schmidt; I Leinhase; E Hasenboehler; S J Morgan; P F Stahel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

Review 3.  "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Erin D Milligan; Steven F Maier
Journal:  Brain Res Rev       Date:  2007-07-13

Review 4.  Remote cell death in the cerebellar system.

Authors:  M T Viscomi; F Florenzano; L Latini; M Molinari
Journal:  Cerebellum       Date:  2009-04-22       Impact factor: 3.847

Review 5.  The astrocyte odyssey.

Authors:  Doris D Wang; Angélique Bordey
Journal:  Prog Neurobiol       Date:  2008-10-01       Impact factor: 11.685

6.  Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation.

Authors:  Muskan Gupta; Gurcharan Kaur
Journal:  Neuromolecular Med       Date:  2018-05-30       Impact factor: 3.843

7.  Protective role of fentanyl in lipopolysaccharide-induced neuroinflammation in BV-2 cells.

Authors:  Jian Wang; Yingjie Jin; Jianchun Li
Journal:  Exp Ther Med       Date:  2018-08-09       Impact factor: 2.447

8.  Both TLR2 and TLR4 are required for the effective immune response in Staphylococcus aureus-induced experimental murine brain abscess.

Authors:  Werner Stenzel; Sabine Soltek; Monica Sanchez-Ruiz; Shizuo Akira; Hrvoje Miletic; Dirk Schlüter; Martina Deckert
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

9.  CCL2 in the Tumor Microenvironment.

Authors:  Tracy O'Connor; Mathias Heikenwalder
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Toll-like receptors in central nervous system glial inflammation and homeostasis.

Authors:  Tammy Kielian
Journal:  J Neurosci Res       Date:  2006-04       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.